MATA NATHAN L. (Chief Scientific Officer) sold 37.5% of their position (1K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $155.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
American depositary share
Shares
−120.00
Price / share
$153.92
Trade value
$18.47K
% of position
American depositary share
Shares
−363.00
Price / share
$154.44
Trade value
$56.06K
% of position
American depositary share
Shares
−173.00
Price / share
$155.48
Trade value
$26.90K
% of position
American depositary share
Shares
−121.00
Price / share
$156.53
Trade value
$18.94K
% of position
American depositary share
Shares
−155.00
Price / share
$157.29
Trade value
$24.38K
% of position
American depositary share
Shares
−68.00
Price / share
$158.11
Trade value
$10.75K
% of position
Net shares
−1K
Net value
-$155.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 5/5/2026 | S · Sale | −120.00 | $153.92 | $18.47K | 4.5% | 2.67K | 2.55K |
| American depositary share Direct | 5/5/2026 | S · Sale | −363.00 | $154.44 | $56.06K | 14.3% | 2.55K | 2.18K |
| American depositary share Direct | 5/5/2026 | S · Sale | −173.00 | $155.48 | $26.90K | 7.9% | 2.18K | 2.01K |
| American depositary share Direct | 5/5/2026 | S · Sale | −121.00 | $156.53 | $18.94K | 6.0% | 2.01K | 1.89K |
| American depositary share Direct | 5/5/2026 | S · Sale | −155.00 | $157.29 | $24.38K | 8.2% | 1.89K | 1.73K |
| American depositary share Direct | 5/5/2026 | S · Sale | −68.00 | $158.11 | $10.75K | 3.9% | 1.73K | 1.67K |
| Total | −1K | -$155.50K | ||||||